Search This Blog

Tuesday, April 29, 2025

Kiniksa Pharma earnings beat by $0.09, revenue topped estimates

 Kiniksa Pharma (NASDAQ: KNSA) reported first quarter EPS of $0.11, $0.09 better than the analyst estimate of $0.02. Revenue for the quarter came in at $137.7M versus the consensus estimate of $131.07M.

Kiniksa Pharma’s stock price closed at $21.47. It is up 9.54% in the last 3 months and up 32.21% in the last 12 months.

Kiniksa Pharma saw positive EPS revisions and negative EPS revisions in the last 90 days. See Kiniksa Pharma’s stock price’s past reactions to earnings here.

https://www.investing.com/news/earnings/kiniksa-pharma-earnings-beat-by-009-revenue-topped-estimates-4010354

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.